David Devos

15.8k total citations · 4 hit papers
234 papers, 9.4k citations indexed

About

David Devos is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David Devos has authored 234 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Neurology, 50 papers in Molecular Biology and 41 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Devos's work include Parkinson's Disease Mechanisms and Treatments (88 papers), Neurological disorders and treatments (59 papers) and Amyotrophic Lateral Sclerosis Research (36 papers). David Devos is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (88 papers), Neurological disorders and treatments (59 papers) and Amyotrophic Lateral Sclerosis Research (36 papers). David Devos collaborates with scholars based in France, Belgium and United Kingdom. David Devos's co-authors include Caroline Moreau, A. Destée, Luc Defebvre, Régis Bordet, Luc Defebvre, Jean-Christophe Devedjian, Kathy Dujardin, James A. Duce, Anne‐Sophie Rolland and Ashley I. Bush and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David Devos

222 papers receiving 9.2k citations

Hit Papers

Ferroptosis, a newly char... 2012 2026 2016 2021 2016 2012 2018 2020 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Devos 4.5k 2.6k 1.8k 1.4k 1.3k 234 9.4k
Régis Bordet 2.5k 0.5× 2.4k 0.9× 1.8k 1.0× 835 0.6× 1.5k 1.2× 313 9.1k
Phil Hyu Lee 5.1k 1.1× 2.0k 0.7× 2.3k 1.3× 547 0.4× 1.4k 1.1× 351 10.4k
Hideki Mochizuki 3.8k 0.8× 3.8k 1.5× 2.9k 1.6× 582 0.4× 1.9k 1.5× 436 11.4k
Xiaoning Han 1.7k 0.4× 3.1k 1.2× 2.8k 1.6× 849 0.6× 3.1k 2.5× 82 9.0k
Linda J. Noble‐Haeusslein 4.2k 0.9× 4.5k 1.7× 2.7k 1.6× 722 0.5× 1.6k 1.3× 132 13.5k
Juan Sanchez‐Ramos 2.8k 0.6× 2.8k 1.1× 2.6k 1.5× 282 0.2× 1.1k 0.9× 149 9.6k
Kazuhiko Nozaki 4.4k 1.0× 2.7k 1.0× 1.5k 0.9× 1.3k 0.9× 1.3k 1.0× 278 10.5k
Italo Biaggioni 3.1k 0.7× 2.4k 0.9× 1.9k 1.1× 771 0.6× 1.4k 1.1× 343 18.0k
Gang Chen 3.4k 0.8× 4.9k 1.9× 1.1k 0.6× 957 0.7× 2.6k 2.0× 415 12.7k
Stephen B. Wharton 2.6k 0.6× 2.8k 1.1× 1.3k 0.8× 544 0.4× 2.3k 1.8× 170 8.9k

Countries citing papers authored by David Devos

Since Specialization
Citations

This map shows the geographic impact of David Devos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Devos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Devos more than expected).

Fields of papers citing papers by David Devos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Devos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Devos. The network helps show where David Devos may publish in the future.

Co-authorship network of co-authors of David Devos

This figure shows the co-authorship network connecting the top 25 collaborators of David Devos. A scholar is included among the top collaborators of David Devos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Devos. David Devos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravez, Séverine, Didier Vertommen, Nicolas Renault, et al.. (2025). LIBX‐A401: A Novel Selective Inhibitor of Acyl‐CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode. Angewandte Chemie International Edition. 64(19). e202500518–e202500518. 4 indexed citations
2.
Timmerman, Kelly, Nicolas Durieux, Nathalie Dutheil, et al.. (2024). Magnetic resonance imaging characterization of an α‐synuclein model of Parkinson's disease. European Journal of Neuroscience. 60(12). 7038–7057. 1 indexed citations
3.
Delila, Liling, Ouada Nebie, Kelly Timmerman, et al.. (2024). Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson’s disease models. Journal of Biomedical Science. 31(1). 87–87. 18 indexed citations
4.
Barras, Alexandre, Rabah Boukherroub, Ching‐Li Tseng, et al.. (2023). Enhancing paracellular and transcellular permeability using nanotechnological approaches for the treatment of brain and retinal diseases. Nanoscale Horizons. 9(1). 14–43. 25 indexed citations
5.
Liu, Shuo, Jean‐Christophe Corvol, Isabelle Bénatru, et al.. (2023). Symptoms assessment and decision to treat patients with advanced Parkinson’s disease based on wearables data. npj Parkinson s Disease. 9(1). 45–45. 5 indexed citations
6.
Mutez, Eugénie, David Devos, Caroline Moreau, et al.. (2023). Indication for molecular testing by multiplex ligation‐dependent probe amplification in parkinsonism. European Journal of Neurology. 30(6). 1667–1675. 2 indexed citations
7.
Nilles, Christelle, et al.. (2023). Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option?. Journal of Movement Disorders. 16(3). 328–330. 3 indexed citations
8.
Kuchcinski, Grégory, Renaud Lopes, Mélanie Leroy, et al.. (2022). Quantitative susceptibility mapping demonstrates different patterns of iron overload in subtypes of early-onset Alzheimer’s disease. European Radiology. 33(1). 184–195. 12 indexed citations
9.
Pagneux, Quentin, Alain Roussel, Christian Cambillau, et al.. (2022). SARS-CoV-2 detection using a nanobody-functionalized voltammetric device. SHILAP Revista de lepidopterología. 2(1). 56–56. 23 indexed citations
10.
Grapperon, Aude‐Marie, Annie Verschueren, Élisabeth Jouve, et al.. (2021). Assessing the upper motor neuron in amyotrophic lateral sclerosis using the triple stimulation technique: A multicenter prospective study. Clinical Neurophysiology. 132(10). 2551–2557. 8 indexed citations
11.
Nebie, Ouada, Lassina Barro, Yu‐Wen Wu, et al.. (2020). Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiationin vitro. Platelets. 32(2). 226–237. 22 indexed citations
12.
Devos, David, et al.. (2020). Efficacy of tDCS for bipolar depression in a patient with spinocerebellar ataxia: A case report. Bipolar Disorders. 22(4). 422–424. 1 indexed citations
13.
Devos, David, Étienne C. Hirsch, & Richard Wyse. (2020). Seven Solutions for Neuroprotection in Parkinson's Disease. Movement Disorders. 36(2). 306–316. 38 indexed citations
14.
Nebie, Ouada, David Devos, Valérie Vingtdeux, et al.. (2019). The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates. Journal of Biomedical Science. 26(1). 89–89. 30 indexed citations
15.
Grolez, Guillaume, Maéva Kyheng, Renaud Lopes, et al.. (2018). MRI of the cervical spinal cord predicts respiratory dysfunction in ALS. Scientific Reports. 8(1). 1828–1828. 29 indexed citations
16.
Baille, Guillaume, Cécile Chenivesse, T. Pérez, et al.. (2018). Dyspnea: An underestimated symptom in Parkinson's disease. Parkinsonism & Related Disorders. 60. 162–166. 38 indexed citations
17.
Masaldan, Shashank, Ashley I. Bush, David Devos, Anne‐Sophie Rolland, & Caroline Moreau. (2018). Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration. Free Radical Biology and Medicine. 133. 221–233. 380 indexed citations breakdown →
18.
Moreau, Caroline, James A. Duce, Olivier Rascol, et al.. (2018). Iron as a therapeutic target for Parkinson's disease. Movement Disorders. 33(4). 568–574. 101 indexed citations
19.
Devos, David, Stéphanie Lejeune, Florence Cormier‐Dequaire, et al.. (2013). Dopa-decarboxylase gene polymorphisms affect the motor response to l-dopa in Parkinson's disease. Parkinsonism & Related Disorders. 20(2). 170–175. 47 indexed citations
20.
Devos, David & Luc Defebvre. (2006). Effect of deep brain stimulation and l-Dopa on electrocortical rhythms related to movement in Parkinson's disease. Progress in brain research. 331–349. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026